UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer

Cancers, 2020-04, Vol.12 (4), p.989

2020

Volltextzugriff (PDF)

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

European urology oncology, 2024-08, Vol.7 (4), p.933-943

2024

Volltextzugriff (PDF)

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Investigational new drugs, 2018-12, Vol.36 (6), p.1060-1071

2018

Volltextzugriff (PDF)

Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer

Clinical genitourinary cancer, 2011-09, Vol.9 (1), p.39-45

2011

Volltextzugriff (PDF)

Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer

Clinical genitourinary cancer, 2011-09, Vol.9 (1), p.31-38

2011

Volltextzugriff (PDF)

Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2

The Journal of biological chemistry, 2006-11, Vol.281 (44), p.33597-33605

2006

Volltextzugriff (PDF)

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Clinical cancer research, 2022-08, Vol.28 (15), p.3248-3255

2022

Volltextzugriff (PDF)

Neutral endopeptidase is a myristoylated protein

Molecular and cellular biochemistry, 2010-02, Vol.335 (1-2), p.173-180

2010

Volltextzugriff (PDF)

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2022-06, Vol.28 (11), p.2237-2247

2022

Volltextzugriff (PDF)

The relevance of BRCA genetics to prostate cancer pathogenesis and treatment

Clinical advances in hematology & oncology, 2011-10, Vol.9 (10), p.748-755

2011

Volltextzugriff (PDF)

Is there a role for LHRH antagonists in prostate cancer?

Oncology (Williston Park, N.Y.), 2009-06, Vol.23 (7), p.632, 635-635

Goodman, Jr, Oscar B

2009

Volltextzugriff (PDF)

Urothelial Bladder Carcinoma With Choriocarcinomatous Differentiation Presenting With a False-Positive Pregnancy Test

The American journal of the medical sciences, 2013-09, Vol.346 (3), p.256-258

2013

Volltextzugriff (PDF)

Enhanced detection of metastatic prostate cancer cells in human plasma with lipid bodies staining

BMC cancer, 2014-02, Vol.14 (1), p.91-91, Article 91

2014

Volltextzugriff (PDF)

Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter

Molecular and cellular endocrinology, 2006-10, Vol.259 (1), p.10-21

2006

Volltextzugriff (PDF)

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Journal of medical case reports, 2009-09, Vol.3 (1), p.9110-9110

2009

Volltextzugriff (PDF)

Targeting DNA damage response to overcome taxane resistance

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.312-312

2018

Volltextzugriff (PDF)

Abstract B017: Role of CYP3A5 in modulating androgen receptor signaling and its relevance in African American prostate cancer patients

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_1), p.B017-B017

2020

Volltextzugriff (PDF)

Novel Antibody Approaches for T-Cell Lymphomas

Clinical lymphoma & myeloma, 2008-12, Vol.8, p.S193-S198

2008

Volltextzugriff (PDF)

Abstract 1311A: CYP3A5 regulation of androgen receptor signaling: Relevance in African American prostate cancer patients and its development as novel target

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1311-1311A

2019

Volltextzugriff (PDF)

Abstract 4650: Effect of prescription CYP3A inducers and inhibitors on response to anti-androgen therapy in prostate cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4650-4650

2016

Volltextzugriff (PDF)

Abstract B001: CYP3A5 promotes AR downstream signaling and contributes to therapeutic resistance

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16_Supplement), p.B001-B001

2018

Volltextzugriff (PDF)

Abstract B48: Effect of concomitant CYP3A5-modulating drugs on androgen-receptor signaling in African American men undergoing androgen deprivation therapy

Cancer epidemiology, biomarkers & prevention, 2018-07, Vol.27 (7_Supplement), p.B48-B48

2018

Volltextzugriff (PDF)

Abstract 3130: CYP3A5 positively regulates androgen receptor signaling in prostate cancer cells: Potential for therapeutic targeting

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3130-3130

2017

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

ThemaCell Line, Tumor

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(58)
magazinearticle
(2)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Humans
(19)
Life Sciences & Biomedicine
(19)
Male
(11)
Oncology
(11)
Prostate Cancer
(8)
Adult
(6)
Aged
(6)
Middle Aged
(6)
Female
(5)
Neoplasm Metastasis
(5)
Prostatic Neoplasms - Pathology
(4)
Treatment Outcome
(4)
Adolescent
(3)
Aged, 80 And Over
(3)
Animals
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Biochemistry
(3)
Biochemistry & Molecular Biology
(3)
Biological Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study

Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer

Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer

Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Neutral endopeptidase is a myristoylated protein

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

The relevance of BRCA genetics to prostate cancer pathogenesis and treatment

Is there a role for LHRH antagonists in prostate cancer?

Urothelial Bladder Carcinoma With Choriocarcinomatous Differentiation Presenting With a False-Positive Pregnancy Test

Enhanced detection of metastatic prostate cancer cells in human plasma with lipid bodies staining

Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Targeting DNA damage response to overcome taxane resistance

Abstract B017: Role of CYP3A5 in modulating androgen receptor signaling and its relevance in African American prostate cancer patients

Novel Antibody Approaches for T-Cell Lymphomas

Abstract 1311A: CYP3A5 regulation of androgen receptor signaling: Relevance in African American prostate cancer patients and its development as novel target

Abstract 4650: Effect of prescription CYP3A inducers and inhibitors on response to anti-androgen therapy in prostate cancer

Abstract B001: CYP3A5 promotes AR downstream signaling and contributes to therapeutic resistance

Abstract B48: Effect of concomitant CYP3A5-modulating drugs on androgen-receptor signaling in African American men undergoing androgen deprivation therapy

Abstract 3130: CYP3A5 positively regulates androgen receptor signaling in prostate cancer cells: Potential for therapeutic targeting

Aktive Filter

Suchergebnisse filtern